Stero Biotechs

STERO Ltd., established in 2017 and headquartered in Israel, is a clinical company dedicated to researching and developing novel and improved cannabidiol (CBD) therapeutic solutions that could benefit millions by alleviating patients' symptoms through the reduction of side effects and the need for steroid treatments.STERO's patent has been approved! In August 2018 in the United States, Stero initiated its Phase IIa clinical trial for Autoimmune Hepatitis (AIH) in May 2019, and the Phase IIa clinical trial for Crohn’s Disease (IBD) will commence in June 2019, with more indications expected in 2019.